A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers
Open Access
- 1 January 2015
- journal article
- review article
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 9s2 (Suppl. 2) , 35-43
Abstract
Immunotherapy for cancer has been a focus 50 years ago. At the time, this treatment was developed prior to cloning of the cytokines, no knowledge of regulatory T-cells, and very little information that mesenchymal stem cells (MSCs) (originally colony forming unit-fibroblasts [CFU-F]) could be licensed by the inflammatory microenvironment to suppress an immune response. Given the information available at that time, mononuclear cells from the peripheral blood were activated ex vivo and then replaced in the patients with tumor. The intent was to harness these activated immune cells to target the cancer cells. These studies did not lead to long-term responses because the activated cells when reinfused into the patients were an advantage to the resident MSCs, which can home the tumor and then become suppressive in the presence of the immune cells. The immune suppression caused by MSCs would also expand regulatory T-cells, resulting instead in tumor protection. As time progressed, these different fields converged into a new approach to use immunotherapy for cancer. This article discusses these approaches and also reviews chimeric antigen receptor in the context of future treatments for solid tumors, including breast cancer.Keywords
This publication has 93 references indexed in Scilit:
- ErbB-targeted CAR T-cell Immunotherapy of CancerImmunotherapy, 2015
- Hematopoietic stem cells for cancer immunotherapyImmunological Reviews, 2013
- Nivolumab plus Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2013
- Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived StromaPLOS ONE, 2012
- Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric PopulationTransplantation and Cellular Therapy, 2010
- Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinomaAIDS, 2008
- High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical CancerCancer Research, 2007
- CTLA-4: new insights into its biological function and use in tumor immunotherapyNature Immunology, 2002
- Cancer--A Biological Approach: I. The Processes Of Control. II. The Significance of Somatic MutationBMJ, 1957
- Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunityProceedings of the Royal Society of London. B. Biological Sciences, 1954